Abstract

CD Microfluidics: Barriers to Commercialization

Alexandra Perebikovsky, Researcher, University of California-Irvine

While CD microfluidics has been around for several decades, it has yet to be commercially adopted for complex molecular diagnostic assays. In this talk, we explore the remaining barriers that prevent CD microfluidics from gaining wider acceptance as a tool for point-of-care diagnostics. We discuss the myth of passive valving, review the latest research on storage and release of reagents in CD devices, and discuss the current challenges and future outlook for assay detection on the disc.